{"id":"W2088802427","doi":"10.1016/j.jaad.2009.05.042","title":"A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti–interferon-alfa monoclonal antibody, in subjects with chronic psoriasis","year":2010,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":80,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research; Innovaderm (Canada)","funders":"","keywords":"Medicine; Psoriasis; Placebo; Monoclonal antibody; Interferon alfa; Double blind; Monoclonal; Internal medicine; Placebo-controlled study; Interferon; Antibody; Dermatology; Immunology; Gastroenterology; Alpha interferon; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001022092,0.0003887997,0.003099858,0.0006565278,0.0001025591,0.000008932087,0.0009831715,0.0002946514,0.00008520036],"category_scores_gemma":[0.0001207555,0.0002249755,0.0004671884,0.0004835015,0.001449729,0.0002103793,0.0001138186,0.001150677,0.000006435131],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004375897,"about_ca_system_score_gemma":0.0003178372,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002474867,"about_ca_topic_score_gemma":0.0002287097,"domain_scores_codex":[0.9956927,0.001721232,0.001619283,0.0003085198,0.0001792991,0.0004789252],"domain_scores_gemma":[0.9952334,0.0008973209,0.003345967,0.0003218662,0.000128563,0.00007294739],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8127673,0.002699418,0.02636356,0.00002549992,0.003145493,0.00006740946,0.001324616,0.00004901672,0.1506475,0.0001015119,0.00006978778,0.002738958],"study_design_scores_gemma":[0.8997946,0.002837748,0.004274355,0.00009077974,0.001553288,0.004344516,0.001066346,0.00002998163,0.08555785,0.00006141003,0.0001426697,0.0002464569],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951848,0.001576751,0.00002735596,0.001225411,0.0006123367,0.001288673,0.00001779013,0.00001085643,0.00005607146],"genre_scores_gemma":[0.9991902,0.0003906382,0.0001258343,0.00007743822,0.00009900238,0.00005050721,0.000006848601,0.0000291581,0.00003038156],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08702736,"threshold_uncertainty_score":0.9174233,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02083832315846544,"score_gpt":0.3237111434332171,"score_spread":0.3028728202747516,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}